Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
An. bras. dermatol; 93 (4), 2018
Abstract: Background: Actinic keratoses are benign intraepithelial skin neoplasms that develop in photoexposed areas and can progress to invasive carcinoma. They are seen frequently in dermatological practice, occurring in 5.1% of consultations. Ingenol mebutate (IM) was recently approved in Brazil as a...